HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
PDF Library
RSS Feeds
Subscribe
Advertising
Partnered Content
Report Store
UsernamePublicRestriction
Tags:

CCA Industries Plus + White Toothpaste Case Referred To FTC By NAD

This article was originally published in The Rose Sheet

  • News
  • The Rose Sheet

Executive Summary

A false advertising case against CCA Industries Plus + White Shades Whiter and Plus + White Plus Peroxide stain remover toothpaste is being referred to the Federal Trade Commission for review.

You may also be interested in...



OTC Permethrin For Lice Still Endorsed Despite Latest Resistance Research

Continued use of permethrin as the front-line treatment for newly diagnosed infestations of head lice is advised by Harvard researchers despite new data showing some lice in the U.S. are resistant to the ingredient. Several OTC lice products, such as Warner-Lambert's Nix, contain permethrin as an active ingredient.

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands

Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle
Table

View full table

Tags:
UsernamePublicRestriction

Register

RS007487

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By